RHOA and breast carcinoma: Since RhoA has been shown to require HIF-1α for activation in breast cancer cells and fibroblasts29, we investigated if HIF-1α is required for FN fibril assembly in response to CoCl2 treatment or the disassembly of fibrils in response to hypoxia.